ProMIS Neurosciences Inc (PMN) - Medical Equipment - Deals and Alliances Profile

ProMIS Neurosciences Inc (PMN) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME14743D
  • |
  • Pages: 57
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, helps in predicting new disease specific epitopes on the molecular surface of misfolded proteins. Based on ProMIS technology, the company is developing antibody therapeutics and diagnostics targeting cancer and amyotrophic lateral sclerosis (ALS). It's products and services include therapeutics, diagnostic kits, diagnostic services, and reagents. ProMIS is headquartered in Toronto, Ontario, Canada.

ProMIS Neurosciences Inc (PMN)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

ProMIS Neurosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

ProMIS Neurosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

ProMIS Neurosciences Inc, Medical Equipment, Deal Details 11

Partnerships 11

Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11

Amorfix Life Sciences Enters Into Co-Development Agreement With Trellis Bioscience 12

Amorfix Life Sciences Enters Into Agreement With Pharma Company For Alzheimer's Disease Diagnostic 13

Amorfix Life Sciences Enters Into Co-Development Agreement With QPS Holdings 14

Equity Offering 15

ProMIS Neurosciences Raises USD5.6 Million in Private Placement of Shares and Warrants 15

ProMIS Neurosciences Raises USD1 Million in Second Tranche of Private Placement of Units 16

ProMIS Neurosciences Raises USD0.4 Million in Private Placement of Units 18

ProMIS Neurosciences Raises USD0.8 Million in Private Placement of Units 19

ProMIS Neurosciences Raises USD0.3 Million in Second and Final Tranche of Private Placement of Shares 20

ProMIS Neurosciences Raises USD0.5 Million in First Tranche of Private Placement of Shares 21

ProMIS Neurosciences to Raise Funds Through Rights Offering of Shares 22

Amorfix Life Sciences Completes Third Tranche Of Private Placement Of Shares And Warrants For USD 1 Million 23

Amorfix Life Sciences Completes Private Placement Of Securities For USD 0.4 Million 24

Amorfix Life Sciences Completes Private Placement Of Units For USD 0.5 Million 25

Amorfix Life Sciences Raises USD0.25 Million In a Private Placement Of Shares 26

Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Shares For USD 0.2 Million 27

Amorfix Life Sciences Completes First Tranche Of Private Placement Of Units For USD 0.5 Million 28

Amorfix Life Sciences Completes Second And Final Tranche Of Private Placement Of Units For USD 0.3 Million 29

Amorfix Life Sciences Completes Private Placement Of Units For USD 0.2 Million 30

Amorfix Life Sciences Completes Private Placement Of Units For USD 1 Million 31

Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Units For USD 0.08 Million 32

ProMIS Neurosciences Inc-Key Competitors 34

ProMIS Neurosciences Inc-Key Employees 35

ProMIS Neurosciences Inc-Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Recent Developments 37

Financial Announcements 37

Aug 14, 2018: Promis Neurosciences reports second quarter 2018 financial results 37

May 11, 2018: ProMIS Neurosciences Announces First Quarter 2018 Results 39

Mar 14, 2018: ProMIS Neurosciences Announces Fiscal Year 2017 Annual Results 41

Nov 13, 2017: ProMIS Neurosciences Announces Third Quarter 2017 Results 43

Aug 11, 2017: ProMIS Neurosciences Announces Second Quarter 2017 Results 45

Jul 10, 2017: ProMIS Neurosciences Provides Second Quarter Update for 2017 47

May 09, 2017: ProMIS Neurosciences Announces Q1 2017 Quarterly Results 48

Mar 30, 2017: ProMIS Neurosciences announces overview of first quarter 2017 progress and outlook for near term value creation 49

Mar 15, 2017: ProMIS Neurosciences Announces Fiscal 2016 Annual Results 50

Corporate Communications 52

Sep 13, 2018: ProMIS Neurosciences appoints James Kupiec, MD as Chief Medical Officer 52

Jun 06, 2017: ProMIS Neurosciences Appoints William C. Mobley to Scientific Advisory Board 53

Mar 22, 2017: ProMIS Neurosciences Announces Appointment of Daniel Geffken as Chief Financial Officer 54

Mar 02, 2017: ProMIS Neurosciences announces appointment of Anthony Giovinazzo to its Board of Directors 55

Other Significant Developments 56

Aug 29, 2018: ProMIS Neurosciences Issues Narrated Overview of Second Quarter 2018 Results 56

Appendix 57

Methodology 57

About GlobalData 57

Contact Us 57

Disclaimer 57

List of Figures

ProMIS Neurosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

ProMIS Neurosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

ProMIS Neurosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

ProMIS Neurosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

List of Tables

ProMIS Neurosciences Inc, Medical Equipment, Key Facts, 2017 2

ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

ProMIS Neurosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

ProMIS Neurosciences Inc, Deals By Market, 2012 to YTD 2018 9

ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11

Amorfix Life Sciences Enters Into Co-Development Agreement With Trellis Bioscience 12

Amorfix Life Sciences Enters Into Agreement With Pharma Company For Alzheimer's Disease Diagnostic 13

Amorfix Life Sciences Enters Into Co-Development Agreement With QPS Holdings 14

ProMIS Neurosciences Raises USD5.6 Million in Private Placement of Shares and Warrants 15

ProMIS Neurosciences Raises USD1 Million in Second Tranche of Private Placement of Units 16

ProMIS Neurosciences Raises USD0.4 Million in Private Placement of Units 18

ProMIS Neurosciences Raises USD0.8 Million in Private Placement of Units 19

ProMIS Neurosciences Raises USD0.3 Million in Second and Final Tranche of Private Placement of Shares 20

ProMIS Neurosciences Raises USD0.5 Million in First Tranche of Private Placement of Shares 21

ProMIS Neurosciences to Raise Funds Through Rights Offering of Shares 22

Amorfix Life Sciences Completes Third Tranche Of Private Placement Of Shares And Warrants For USD 1 Million 23

Amorfix Life Sciences Completes Private Placement Of Securities For USD 0.4 Million 24

Amorfix Life Sciences Completes Private Placement Of Units For USD 0.5 Million 25

Amorfix Life Sciences Raises USD0.25 Million In a Private Placement Of Shares 26

Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Shares For USD 0.2 Million 27

Amorfix Life Sciences Completes First Tranche Of Private Placement Of Units For USD 0.5 Million 28

Amorfix Life Sciences Completes Second And Final Tranche Of Private Placement Of Units For USD 0.3 Million 29

Amorfix Life Sciences Completes Private Placement Of Units For USD 0.2 Million 30

Amorfix Life Sciences Completes Private Placement Of Units For USD 1 Million 31

Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Units For USD 0.08 Million 32

ProMIS Neurosciences Inc, Key Competitors 34

ProMIS Neurosciences Inc, Key Employees 35

ProMIS Neurosciences Inc, Subsidiaries 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

ProMIS Neurosciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17835
Site License
USD 500 INR 35670
Corporate User License
USD 750 INR 53505

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com